Literature DB >> 24406680

Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

Sebastian Willenborg1, Beate Eckes1, Jürgen Brinckmann2, Thomas Krieg3, Ari Waisman4, Karin Hartmann1, Axel Roers5, Sabine A Eming6.   

Abstract

Conclusive evidence for the impact of mast cells (MCs) in skin repair is still lacking. Studies in mice examining the role of MC function in the physiology and pathology of skin regenerative processes have obtained contradictory results. To clarify the specific role of MCs in regenerative conditions, here we used a recently developed genetic mouse model that allows conditional MC ablation to examine MC-specific functions in skin. This mouse model is based on the cell type-specific expression of Cre recombinase in connective tissue-type MCs under control of the Mcpt5 promoter and the Cre-inducible diphtheria toxin receptor-mediated cell lineage ablation by diphtheria toxin. In response to excisional skin injury, genetic ablation of MCs did not affect the kinetics of reepithelialization, the formation of vascularized granulation tissue, or scar formation. Furthermore, genetic ablation of MCs failed to prevent the development of skin fibrosis upon bleomycin challenge. The amount of deposited collagen and the biochemistry of collagen fibril crosslinks within fibrotic lesions were comparable in MC-depleted and control mice. Collectively, our findings strongly suggest that significant reduction of MC numbers does not affect skin wound healing and bleomycin-induced fibrosis in mice, and provide to our knowledge previously unreported insight in the long-debated contribution of MCs in skin regenerative processes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24406680     DOI: 10.1038/jid.2014.12

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  36 in total

1.  Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice.

Authors:  Yoshinori Iba; Aya Shibata; Mizuho Kato; Tohru Masukawa
Journal:  Int Immunopharmacol       Date:  2004-12-20       Impact factor: 4.932

2.  Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

Authors:  Peter A Nigrovic; Daniel H D Gray; Tatiana Jones; Jenny Hallgren; Frank C Kuo; Blair Chaletzky; Michael Gurish; Diane Mathis; Christophe Benoist; David M Lee
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

3.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.

Authors:  Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

Review 4.  Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.

Authors:  Toshiyuki Yamamoto; Kiyoshi Nishioka
Journal:  Exp Dermatol       Date:  2005-02       Impact factor: 3.960

5.  Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin.

Authors:  Claudia Waskow; Susanne Bartels; Susan M Schlenner; Celine Costa; Hans-Reimer Rodewald
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

6.  Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.

Authors:  T Yamamoto; Y Takahashi; S Takagawa; I Katayama; K Nishioka
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

7.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

8.  Identification of a committed precursor for the mast cell lineage.

Authors:  H R Rodewald; M Dessing; A M Dvorak; S J Galli
Journal:  Science       Date:  1996-02-09       Impact factor: 47.728

9.  Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis.

Authors:  Maria Antsiferova; Caroline Martin; Marcel Huber; Thorsten B Feyerabend; Anja Förster; Karin Hartmann; Hans-Reimer Rodewald; Daniel Hohl; Sabine Werner
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

10.  Evidence that mast cells are not required for healing of splinted cutaneous excisional wounds in mice.

Authors:  Allison C Nauta; Monica Grova; Daniel T Montoro; Andrew Zimmermann; Mindy Tsai; Geoffrey C Gurtner; Stephen J Galli; Michael T Longaker
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

View more
  25 in total

Review 1.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Rethinking the potential roles of mast cells in skin wound healing and bleomycin-induced skin fibrosis.

Authors:  Stephen J Galli
Journal:  J Invest Dermatol       Date:  2014-07       Impact factor: 8.551

4.  JID VisualDx quiz: July 2014. Graft-versus-host disease.

Authors:  Alexander Badiavas; Robert S Kirsner
Journal:  J Invest Dermatol       Date:  2014-07       Impact factor: 8.551

5.  Indirect effects of immunological tolerance to a regular dietary protein reduce cutaneous scar formation.

Authors:  Thiago Anselmo Cantaruti; Raquel Alves Costa; Kênia Soares de Souza; Nelson Monteiro Vaz; Cláudia Rocha Carvalho
Journal:  Immunology       Date:  2017-04-06       Impact factor: 7.397

Review 6.  Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.

Authors:  Jacqueline Larouche; Sumit Sheoran; Kenta Maruyama; Mikaël M Martino
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

7.  Mast cells are critical for controlling the bacterial burden and the healing of infected wounds.

Authors:  C Zimmermann; D Troeltzsch; V A Giménez-Rivera; S J Galli; M Metz; M Maurer; F Siebenhaar
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 8.  Molecular and cellular basis of scleroderma.

Authors:  Beate Eckes; Pia Moinzadeh; Gerhard Sengle; Nico Hunzelmann; Thomas Krieg
Journal:  J Mol Med (Berl)       Date:  2014-07-18       Impact factor: 4.599

Review 9.  Wound repair and regeneration: mechanisms, signaling, and translation.

Authors:  Sabine A Eming; Paul Martin; Marjana Tomic-Canic
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

10.  Topical Gynura procumbens as a Novel Therapeutic Improves Wound Healing in Diabetic Mice.

Authors:  Nutda Sutthammikorn; Volaluck Supajatura; Hainan Yue; Miho Takahashi; Sunee Chansakaow; Nobuhiro Nakano; Pu Song; Takasuke Ogawa; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Plants (Basel)       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.